JohnLawsonGrahamMD

PubMed

• Resource utilization and costs associated with using insulin therapy within a newly diagnosed type 2 diabetes mellitus population.
  Bell, K.,Parasuraman, S.,Raju, A.,Shah, M.,Graham, J.,Denno, M.> ;J Manag Care Spec Pharm. 2015 Mar 03
• Evaluation of medical costs avoided when new oral anticoagulants are used for extended treatment of venous thromboembolism based on clinical trial results.
  Amin, A.,Jing, Y.,Trocio, J.,Lin, J.,Lingohr-Smith, M.,Graham, J.> ;J. Thromb. Thrombolysis. 2014 Dec 17
• Evaluation of medical costs associated with use of new oral anticoagulants compared with standard therapy among venous thromboembolism patients.
  Amin, A.,Jing, Y.,Trocio, J.,Lin, J.,Lingohr-Smith, M.,Graham, J.> ;J Med Econ. 2014 Aug 01
• 2 citations
  Health Care Burden of Dyspepsia Among Nonvalvular Atrial Fibrillation Patients
  Michael H. Kim, Kelly F Bell, Dinara Makenbaeva, Daniel Wiederkehr, Jay Lin, John Graham> ;Journal of Managed Care & Specialty Pharmacy. 2014 Apr 1
• Estimation of the impact of warfarin's time-in-therapeutic range on stroke and major bleeding rates and its influence on the medical cost avoidance associated with nov...
  Amin, A.,Deitelzweig, S.,Jing, Y.,Makenbaeva, D.,Wiederkehr, D.,Lin, J.,Graham, J.> ;J. Thromb. Thrombolysis. 2014 Jan 31
• The Chinese negotiation.
  Graham, J.L., Lam, N.M.> ;Harv Bus Rev. 2003 Oct
• Economic implications of weight change in patients with type 2 diabetes mellitus.
  Bell, K.,Parasuraman, S.,Shah, M.,Raju, A.,Graham, J.,Lamerato, L.,D'Souza, A.> ;Am J Manag Care. 2014 Oct 09
• Join now to see all